Schizophrenia - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H2 2020, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape. Schizophrenia is a chronic, severe, and disabling brain...
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020 Summary 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - The 5-HT6 receptor is a subtype of 5-HT receptor that binds the endogenous neurotransmitter serotonin. Blockade of 5-HT6 receptors showed to increase glutamatergic...
Central Nervous Systems Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Central Nervous Systems Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Central...
Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Therapeutic Drug Monitoring Tests pipeline products with...
Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inborn Gene or Chromosome Alterations...
Dementia Associated With Alzheimer’s Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Dementia Associated With Alzheimer’s Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Dementia Associated With Alzheimer’s Disease Clinical trials scenario....
The North America neuromodulation market is projected to reach US$ 6,612.00 millionby2027 from US$3,029.72million in 2019; it is anticipated to grow at a CAGR of 10.6% from 2020 to 2027.Themarket growth is attributed to increasing incidence of neurological disorders and developments in neuromodulation technology across the region. Depression...
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020 Summary 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) pipeline Target constitutes close to 13 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes....
Metabotropic Glutamate Receptor 5 - Pipeline Review, H2 2020 Summary Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Metabotropic glutamate receptor 5 (mGluR5) is a G protein-coupled receptor. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding...
Metabotropic Glutamate Receptor 2 - Pipeline Review, H2 2020 Summary According to the recently published report ’Metabotropic Glutamate Receptor 2 - Pipeline Review, H2 2020’; Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 12 molecules. Out of which...